Literature DB >> 1968371

Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.

F P Maesen1, J J Smeets, H L Gubbelmans, P G Zweers.   

Abstract

The bronchodilator effects were compared in 16 stable asthma patients for 12 hours after either 12 micrograms formoterol or 200 micrograms salbutamol from a metered-dose aerosol in a randomized, double-blind, crossover study. The FEV1 measured before 1, 2, 4, 6, 8, 10 and 12 hours after administration was used as the parameter. From 2 hours onwards after dosage, the bronchodilator effect of formoterol was statistically significantly greater than that of salbutamol. The effect of formoterol lasted longer, and even after 12 hours, the FEV1 was still 20 percent above the baseline value. This is clinically significant and offers new possibilities for treatment of the so-called "morning dip." Both agents were well tolerated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968371     DOI: 10.1378/chest.97.3.590

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

Review 1.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 2.  Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Authors:  D Faulds; L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

3.  Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol.

Authors:  A Szczuka; M Wennerberg; A Packeu; G Vauquelin
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

4.  Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.

Authors:  A Lindén; A Bergendal; A Ullman; B E Skoogh; C G Löfdahl
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

5.  Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.

Authors:  E Y Derom; R A Pauwels
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

6.  Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.

Authors:  A Wallin; T Sandström; L Rosenhall; B Melander
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

Review 7.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 8.  Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

Authors:  B J Lipworth; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

9.  Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol.

Authors:  A R Kompa; P Molenaar; R J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

10.  Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.

Authors:  Jan Lötvall; Stephen Langley; Ashley Woodcock
Journal:  Respir Res       Date:  2006-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.